期刊文献+

尼群地平联合卡托普利治疗原发性高血压3年降压疗效观察 被引量:1

下载PDF
导出
摘要 目的:探讨中短效降压药物联合治疗原发性高血压的达标率、依从性,不良反应。方法:对98例农牧民高血压患者使用中短效降压药物联合降压治疗,采用治疗前后自身对照的实验方法重点分析中短效降压药物联合治疗的达标率、依从性,不良反应,心脑血管并发症。结果:中短效降压药物联合降压治疗中使用2种降压药物的患者35.7%,需要3种药物64.3%,均使用>2种降压药物联合。经降压治疗36个月后收缩压平均下降27.7mmHg,舒张压平均下降15.3mmHg,血压达标率36个月平均21.33%。结论:与长效降压药物价格相比中短效降压药物联合价格便宜,可大大提高农牧民高血压患者治疗依从性。中短效降压药物联合降压治疗使高血压患者平均收缩压下降18%,平均舒张压下降19%。血压达标率从1.5%上升至21.33%。
出处 《中国社区医师(医学专业)》 2011年第21期21-21,共1页
  • 相关文献

参考文献2

二级参考文献6

  • 1Pepine C J,Handberg EM,Cooper-DeHoff RM,et al.A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease.The International Verapamil-Trandolapril Study (INVEST):a randomized controlled trial.JAMA,2003,290:2805-2816.
  • 2Weber MA,Julius S,Kjeldsen SE,et al.Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.Lancet,2004,363:2049-2051.
  • 3Mourad JJ,Waeber B,Zannad F,et al.Comparison of different therapeutic strategies in hypertension:a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach.J Hypertens,2004,22:2379-2386.
  • 4Dahlof B,Sever PS,Poulter NR,et al.Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required,in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):a multicentre randomised controlled trial.Lancet,2005,366:895-906.
  • 5Pickkers P,Garcha RS,Schachter M,et al.Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide.Hypertension,1999,33:1043-1048.
  • 6Sturkenboom M,Picelli G,Dieleman JP,et al.Patient adherence and persistence with antihypertensive therapy:one-versus two-pill combination.Presented at the 15th European Meeting on Hypertension,Milan,Italy,June 17-21,2005.

共引文献67

同被引文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部